Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    52,415.41
    +573.12 (+1.11%)
     
  • CMC Crypto 200

    1,371.97
    +59.35 (+4.52%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Cell Lysis Market Experiences Robust Growth, Expected to Achieve a CAGR of 6.79% Through 2028

Company Logo
Company Logo

Global Cell Lysis Market

Global Cell Lysis Market
Global Cell Lysis Market

Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Lysis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Cell Lysis Market Overview

The Global Cell Lysis Market is currently undergoing a significant upsurge in growth, with its valuation reaching USD 3.04 billion in 2022. This market is projected to continue expanding rapidly with a compound annual growth rate (CAGR) of 6.79% through to 2028, powered by the increasing prevalence of cell-based research and the escalating need for diagnostic applications in pharmaceuticals, biotechnology, and healthcare sectors.



Key Drivers of Market Expansion

A foundational driver of market expansion remains the biopharmaceutical sector's progress in drug development and personalized medicine. The rising interest and advancements in genomics and proteomics research also enhance the demand for effective cell lysis methods, which are required for the extraction and analysis of nucleic acids and proteins. Technological innovation further propels the market, as automated cell lysis systems, robotics, and artificial intelligence expand the potential of cell-based diagnostics and research.

Challenges within the Cell Lysis Market

However, the industry is not without its challenges. The high cost of cell lysis equipment and reagents remains a barrier for many research facilities. Furthermore, issues such as sample contamination, cross-contamination, and the complexity of processing various sample types present ongoing hurdles to the market. These challenges necessitate the implementation of rigorous quality control measures and the continual advancement of cell lysis techniques.

Regional Market Dynamics and Leading Participants

Regionally, North America holds the dominant position in the cell lysis market due to its advanced healthcare infrastructure and strong research ecosystem. Within the segmental insights, the Reagents category had a notable market share in 2022, attributed to its critical role in the cell lysis process and the diverse range of reagents available. Similarly, the use of mammalian cells in cell cultures for biomanufacturing has made the mammalian cells segment another dominant force in the market.

Future Market Trends

Emerging trends in the cell lysis market are closely tied to the increasing demand for biologics and the move toward personalized medicine. Biopharmaceutical advancements have increased the necessity for precise cell lysis methodologies vital for these sophisticated treatments. Genomics and proteomics research continues to drive demand for cell lysis solutions as well, as they are essential for the isolation of DNA, RNA, and proteins for groundbreaking research.

Sectoral Analysis

The detailed sectoral analysis of the market provides insights into the instruments and reagents available, diverse cell types catered to, and the different end users, ranging from biotechnology companies to academic institutes.

Recognized members participating in the Cell Lysis Market include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, and several other industry leaders who are contributing to the growth and innovation within this vital sector.

The dynamics of the Global Cell Lysis Market reflect the present and future importance of cell-based research in improving our understanding of diseases, advancing medical treatments, and our overall pursuit of scientific knowledge.

ADVERTISEMENT

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories Inc.

  • Danaher Corporation

  • Eppendorf AG

  • Hoffmann-La Roche Ltd.

  • Labfreez Instruments Group Co. Ltd.

  • Merck KGaA

  • Qsonica LLC

  • Takara Bio Inc.

  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/r22u5g

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900